There are several cytokines which execute the inflammatory cascade, such as tumor necrosis factor-alpha (TNF-α), and it has been suggested that targeted inhibition of TNF-α may reduce the autoimmune inflammatory conditions, indicating that inhibition of TNF-α might be a potential therapeutic strategy to reduce the complications associated with COVID-19 [37]. This evidence concerns the gene TNF and COVID-19.